SCHEMBL7992180

SCHEMBL7992180

O=c1nc(-c2ccccn2)[nH]c2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
GLA P06280 1/20 0.45
HTT P42858 1/20 0.45
UBE2N P61088 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CNOT7 Q9UIV1 2/20 0.43
PARN O95453 1/20 0.43
MAPK1 P28482 2/20 0.43
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
CBFB Q13951 1/20 0.41
YTHDC1 Q96MU7 2/20 0.41
P2RX7 Q99572 2/20 0.40
FSCN1 Q16658 1/20 0.40
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.39
HSP90AA1 P07900 1/20 0.39
AGTR1 P30556 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985494 0.90 CNOT7 (0.52) SMN1; SMN2HTTL3MBTL1CNOT7PARN
SCHEMBL7991792 0.88 ALDH1A1 (0.44) SMN1; SMN2HTTCNOT7PARNMETAP2
SCHEMBL7974009 0.88 METAP2 (0.41) CNOT7PARNMETAP2METAP1CBFB
SCHEMBL7988669 0.86 PARN (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7985461 0.85 TP53 (0.48) YTHDC1P2RX7NPC1RAB9A
SCHEMBL7973628 0.85 SMN1; SMN2 (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL8056886 0.84 SMN1; SMN2 (0.46) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991535 0.84 CNOT7 (0.43) SMN1; SMN2HTTL3MBTL1CNOT7PARN
SCHEMBL7974054 0.84 EGLN1 (0.44) SMN1; SMN2HTTL3MBTL1CNOT7PARN
SCHEMBL7992174 0.84 SMN1; SMN2 (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed